Small study examines risks of injection treatment for Children's facial vein blemishes
NCT ID NCT04930952
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looked at the side effects of using ethanol-amine oleate injections to treat venous malformations (abnormal veins) on the face and jaw in 15 children. The goal was to see how well the treatment worked and what complications might occur. The study is already completed.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ethanol-amine oleate
- What this could lead to
- If successful, this could help doctors better understand the safety of this treatment for children with facial venous malformations.
- What could go wrong
- This is a very small, completed study with only 15 children, so results may not apply to everyone. The treatment itself can cause side effects like pain or swelling.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
15 people
The number who actually took part.
- Started
-
Feb 2019
- Finished
-
Mar 2021
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Pediatric patients of age up to 12 years having maxillofacial venous malformations
- Ages
-
Up to 12 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: maxillofacial venous malformation \- Exclusion Criteria: 1. Patients with lung, liver, or kidney diseases 2. Patients with Klippel-Trenaunay syndrome 3. Patients mental or physical disabilities
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Venous malformation are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Suez Canal University
Ismailia, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a cancer drug shrink birthmarks? bleomycin injections put to the test
- New hope for rare blood vessel disorder: targeted drug shows promise
- New hope for rare blood vessel disorders: everolimus trial launches
- Weekly pill could tame painful birthmarks with fewer side effects
- New registry sheds light on rare overgrowth diseases
- New hope for rare vascular malformations: targeted drugs enter trial